These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 12648223)
1. Genetic heterogeneity in erythrokeratodermia variabilis: novel mutations in the connexin gene GJB4 (Cx30.3) and genotype-phenotype correlations. Richard G; Brown N; Rouan F; Van der Schroeff JG; Bijlsma E; Eichenfield LF; Sybert VP; Greer KE; Hogan P; Campanelli C; Compton JG; Bale SJ; DiGiovanna JJ; Uitto J J Invest Dermatol; 2003 Apr; 120(4):601-9. PubMed ID: 12648223 [TBL] [Abstract][Full Text] [Related]
2. A new, recurrent mutation of GJB3 (Cx31) in erythrokeratodermia variabilis. Morley SM; White MI; Rogers M; Wasserman D; Ratajczak P; McLean WH; Richard G Br J Dermatol; 2005 Jun; 152(6):1143-8. PubMed ID: 15948974 [TBL] [Abstract][Full Text] [Related]
3. Erythrokeratodermia variabilis: report of two cases and a novel missense variant in GJB4 encoding connexin 30.3. Kokotas H; Papagiannaki K; Grigoriadou M; Petersen MB; Katsarou A Eur J Dermatol; 2012; 22(2):182-6. PubMed ID: 22266302 [TBL] [Abstract][Full Text] [Related]
4. The spectrum of mutations in erythrokeratodermias--novel and de novo mutations in GJB3. Richard G; Brown N; Smith LE; Terrinoni A; Melino G; Mackie RM; Bale SJ; Uitto J Hum Genet; 2000 Mar; 106(3):321-9. PubMed ID: 10798362 [TBL] [Abstract][Full Text] [Related]
6. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Richard G; Smith LE; Bailey RA; Itin P; Hohl D; Epstein EH; DiGiovanna JJ; Compton JG; Bale SJ Nat Genet; 1998 Dec; 20(4):366-9. PubMed ID: 9843209 [TBL] [Abstract][Full Text] [Related]
7. Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis. Macari F; Landau M; Cousin P; Mevorah B; Brenner S; Panizzon R; Schorderet DF; Hohl D; Huber M Am J Hum Genet; 2000 Nov; 67(5):1296-301. PubMed ID: 11017804 [TBL] [Abstract][Full Text] [Related]
8. Erythrokeratoderma variabilis caused by a recessive mutation in GJB3. Fuchs-Telem D; Pessach Y; Mevorah B; Shirazi I; Sarig O; Sprecher E Clin Exp Dermatol; 2011 Jun; 36(4):406-11. PubMed ID: 21564177 [TBL] [Abstract][Full Text] [Related]
9. Molecular interaction of connexin 30.3 and connexin 31 suggests a dominant-negative mechanism associated with erythrokeratodermia variabilis. Plantard L; Huber M; Macari F; Meda P; Hohl D Hum Mol Genet; 2003 Dec; 12(24):3287-94. PubMed ID: 14583444 [TBL] [Abstract][Full Text] [Related]
10. Linkage studies in erythrokeratodermias: fine mapping, genetic heterogeneity and analysis of candidate genes. Richard G; Lin JP; Smith L; Whyte YM; Itin P; Wollina U; Epstein E; Hohl D; Giroux JM; Charnas L; Bale SJ; DiGiovanna JJ J Invest Dermatol; 1997 Nov; 109(5):666-71. PubMed ID: 9347797 [TBL] [Abstract][Full Text] [Related]
11. Erythrokeratodermia variabilis et progressiva due to a novel mutation in GJB4. Zhang X; Xu P; Lu J; Ding Y; Gu J; Shi Y Exp Dermatol; 2022 Apr; 31(4):594-599. PubMed ID: 34717022 [TBL] [Abstract][Full Text] [Related]
12. Two de novo GJA1 mutation in two sporadic patients with erythrokeratodermia variabilis et progressiva. Li C; Liang J; Chen P; Zeng K; Xue R; Tian X; Liang L; Wang Q; Shi M; Zhang X Mol Genet Genomic Med; 2019 Jun; 7(6):e670. PubMed ID: 30924322 [TBL] [Abstract][Full Text] [Related]
13. Novel and recurrent connexin 30.3 and connexin 31 mutations associated with erythrokeratoderma variabilis. Scott CA; O'Toole EA; Mohungoo MJ; Messenger A; Kelsell DP Clin Exp Dermatol; 2011 Jan; 36(1):88-90. PubMed ID: 21188847 [TBL] [Abstract][Full Text] [Related]
14. Erythrokeratodermia variabilis et progressiva. Ishida-Yamamoto A J Dermatol; 2016 Mar; 43(3):280-5. PubMed ID: 26945536 [TBL] [Abstract][Full Text] [Related]
15. Clinical variability of the GJB4:c.35G > A gene variant: a study of a large Brazilian erythrokeratodermia pedigree. de Oliveira RTG; Christofolini DM; Criado PR; Lacaz Martins E; Kelsell D; Machado Filho CDS Int J Dermatol; 2020 Jun; 59(6):722-725. PubMed ID: 32311086 [TBL] [Abstract][Full Text] [Related]
16. A mutation in GJB3 is associated with recessive erythrokeratodermia variabilis (EKV) and leads to defective trafficking of the connexin 31 protein. Gottfried I; Landau M; Glaser F; Di WL; Ophir J; Mevorah B; Ben-Tal N; Kelsell DP; Avraham KB Hum Mol Genet; 2002 May; 11(11):1311-6. PubMed ID: 12019212 [TBL] [Abstract][Full Text] [Related]
17. The connexin31 F137L mutant mouse as a model for the human skin disease erythrokeratodermia variabilis (EKV). Schnichels M; Wörsdörfer P; Dobrowolski R; Markopoulos C; Kretz M; Schwarz G; Winterhager E; Willecke K Hum Mol Genet; 2007 May; 16(10):1216-24. PubMed ID: 17446259 [TBL] [Abstract][Full Text] [Related]
18. Screening for mutations in the GJB3 gene in Brazilian patients with nonsyndromic deafness. Alexandrino F; Oliveira CA; Reis FC; Maciel-Guerra AT; Sartorato EL J Appl Genet; 2004; 45(2):249-54. PubMed ID: 15131355 [TBL] [Abstract][Full Text] [Related]
19. Divergent effects of two sequence variants of GJB3 (G12D and R32W) on the function of connexin 31 in vitro. Rouan F; Lo CW; Fertala A; Wahl M; Jost M; Rodeck U; Uitto J; Richard G Exp Dermatol; 2003 Apr; 12(2):191-7. PubMed ID: 12702148 [TBL] [Abstract][Full Text] [Related]
20. Expanding the clinical phenotype associated with NIPAL4 mutation: Study of a Tunisian consanguineous family with erythrokeratodermia variabilis-Like Autosomal Recessive Congenital Ichthyosis. Charfeddine C; Laroussi N; Mkaouar R; Jouini R; Khayat O; Redissi A; Mosbah A; Dallali H; Chedly Debbiche A; Zaouak A; Fenniche S; Abdelhak S; Hammami-Ghorbel H PLoS One; 2021; 16(10):e0258777. PubMed ID: 34669720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]